Document:

omed-ex101_28.htm

 

Exhibit 10.1

 

AMENDMENT 6 TO THE 

COLLABORATION AND OPTION AGREEMENT

 

This Amendment 6 to the Collaboration and Option Agreement (the “Amendment”) is made and entered into on June 13, 2018 (the “Amendment Date”), by and between OncoMed Pharmaceuticals, Inc., a Delaware corporation located at 800 Chesapeake Drive, Redwood City, California 94063, United States of America (“OncoMed”), and Bayer AG, a German corporation located at Müllerstrasse 178, 13353 Berlin, Germany (“Bayer”). OncoMed and Bayer are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”

recitals

Whereas, OncoMed and Bayer Pharma AG (previously acting under the name Bayer Schering Pharma AG; hereinafter “BSP”) entered into a Collaboration and Option Agreement effective as of June 15, 2010, which was amended various times (as amended, the “Agreement”), pursuant to which agreement they undertook to collaborate to discover and develop biologic and small molecule compounds directed to targets within the Wnt cellular pathway; 

Whereas, BSP has leased its business to Bayer effective January 1, 2017 and has assigned the Collaboration and Option Agreement as of such date;

Whereas, the discovery of small molecule compounds, [***];

Whereas, the Parties have agreed to adjust the Small Molecule Research Term and the period and the terms and conditions for Small Molecule Advancement;   

 

AMENDMENT

Now, Therefore, in consideration of the foregoing and the mutual agreements set forth below, the Parties agree as follows:

1.  Any capitalized terms used in this Amendment shall have the meaning set forth in the Agreement, unless otherwise defined herein.

2.  Section 1.133 of the Agreement shall be amended and restated in its entirety to read as follows:

“1.133  “Small Molecule Advancement” means the decision by Bayer to advance Small Molecule Collaboration Compounds into the Collaboration for further Development and potential Commercialization and to obtain the license set forth on Section 5.1.1, which shall be deemed to occur upon [***].”

3.  Section 1.137 of the Agreement shall be amended and restated in its entirety to read as follows:

“1.137  “Small Molecule Research Term” means the period commencing from the Effective Date and ending upon the [***] to occur of either (a) [***].”

  

	
[***]
	
Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

 

1

 

4.  The first three sentences of Section 3.2 shall be amended and restated to read as follows:

“Small Molecule Advancement.  Subject to the terms and conditions of this Agreement, OncoMed hereby grants to Bayer the exclusive right, at any time during the time period set forth in this Section 3.2, to elect to advance Small Molecule Collaboration Compounds into the Collaboration for further Development and potential Commercialization and to obtain the license under Section 5.1.1 with respect thereto. To exercise such right, Bayer shall notify OncoMed in writing, which notification shall be made, if at all, prior to the earlier of (a) [***]. Upon OncoMed’s receipt of such notice, all Small Molecule Collaboration Compounds shall be designated as BSP Development Compounds. [...]”

5.  Exhibit 6.3.1 to the Agreement shall be replaced with regard to Small Molecule Collaboration Compounds with the updated Exhibit 6.3.1 attached to this Amendment as Exhibit A.

6.  Section 6.3.3 of the Agreement shall be deleted in its entirety.

7.  The second sentence of Section 11.1 shall be amended and restated to read as follows:

“[...] If Bayer does not exercise its Small Molecule Advancement right by providing notice thereof to OncoMed in accordance with Section 3.2 within the time period set forth in Section 3.2, this Agreement will expire within thirty (30) days after the expiration of the time period set forth in Section 3.2. [...]”

8.  All other terms and conditions of the Agreement shall remain in full force and effect.

9.  This Amendment may be executed in counter-parts with the same effect as if both Parties had signed the same document. All such counterparts shall be deemed an original, shall be construed together and shall constitute one and the same instrument. Signatures to this Amendment transmitted by facsimile, by email in “portable document format” (“.pdf”), or by any other electronic means intended to preserve the original graphic and pictorial appearance of this Amendment shall have the same effect as physical delivery of the paper document bearing original signature.

10.  This Amendment, together with the Exhibit hereto and the Agreement and all Exhibits thereto, constitutes the entire Agreement between the Parties as to the subject matter of this Amendment, and supersedes and merges all prior and contemporaneous negotiations, representations, agreements and understandings regarding the same.

 

[Next page is the signature page.]

 

	
[***]
	
Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

 

2

 

IN WITNESS WHEREOF, the Parties have caused this Amendment to be executed by their respective duly authorized officers as of the Amendment Date.

 

		
	
OncoMed Pharmaceuticals, Inc.
	
Bayer AG

	
 
	
 

	
By:/s/ John Lewicki
	
By:ppa. /s/ Karl Ziegelbauer

	
John Lewicki
	
Dr. Karl Ziegelbauer

	
President and CEO
	
Head of Therapeutic Research Groups

	
 
	
 

	
 
	
By:ppa. /s/ Hans Lindner

	
 
	
Dr. Hans Lindner

	
 
	
Head of Global External Innovation & Alliances

 

 

	
[***]
	
Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

 

3

 

Exhibit A

 

Exhibit 6.3.1

 

Milestone Payments for Small Molecule Collaboration Compounds

 

 

 

		
	
Milestone Event
	
Payment

[***]

 

	
 
	
Small Molecule Collaboration Compound

 

 

	
[***] 1

 
	
[***]

 

	
	 

	
1
	
 For purposes of this Exhibit 6.3.1, [***] means the [***] have been satisfied.

	
[***]
	
Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.

 

4EXHIBIT 10.1

  

AGREEMENT TO EXCHANGE SECURITIES

BETWEEN

GOLDEN EAGLE INTERNATIONAL, INC.

AND

ADVANTEGO TECHNOLOGIES, INC.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1

INDEX

 

INDEX

 

	 	 Page
	 	 
	
ARTICLE I - EXCHANGE OF SECURITIES

	5
	 	 	 	 	 
	
ARTICLE II - REPRESENTATIONS AND WARRANTIES

	
5

	 	
2.01

	
-

	
Organization

	5
	 	
2.02

	
-

	
Capital 

	
5

	 	
2.03

	
-

	
Directors and Officers 

	
5

	 	
2.04

	
-

	
Financial Statements 

	
5

	 	
2.05

	
-

	
Absence of Changes 

	
6

	 	
2.06

	
-

	
Absence of Undisclosed Liabilities 

	
6

	 	
2.07

	
-

	
Tax Returns 

	
6

	 	
2.08

	
-

	
Corporate Matters

	
6

	 	
2.09

	
-

	
Intellectual Property 

	
6

	 	
2.l0

	
-

	
Contracts and Leases 

	
6

	 	
2.11

	
-

	
Insurance Policies 

	
6

	 	
2.12

	
-

	
Compliance with Laws 

	
6

	 	
2.13

	
-

	
Litigation 

	
7

	 	
2.14

	
-

	
Ability to Carry Out Obligations 

	
7

	 	
2.15

	
-

	
Full Disclosure 

	
7

	 	
2.16

	
-

	
Assets 

	
7

	 	
2A

	
-

	
Organization 

	
7

	 	
2B

	
-

	
Capital 

	
7

	 	
2C

	
-

	
Directors and Officers, Compensation; Banks 

	
7

	 	
2D

	
-

	
Financial Statements 

	
7

	 	
2E

	
-

	
Absence of Changes 

	
8

	 	
2F

	
-

	
Absence of Undisclosed Liabilities 

	
8

	 	
2G

	
-

	
Tax Returns 

	
8

	 	
2H

	
-

	
Corporate Matters

	
8

	 	
2I

	
-

	
Intellectual Property 

	
8

	 	
2J

	
-

	
Contracts and Leases 

	
8

	 	
2K

	
-

	
Insurance Policies 

	
9

	 	
2L

	
-

	
Compliance with Laws 

	
9

	 	
2M

	
-

	
Litigation 

	
9

	 	
2N

	
-

	
Ability to Carry Out Obligations 

	
9

	 	
2O

	
-

	
Full Disclosure

	
9

	 	
2P

	
-

	
Assets 

	
9

	 	 	 	 	 
	
ARTICLE III - OBLIGATIONS BEFORE CLOSING

	10
	 	
3.0l

	
-

	
Investigative Rights 

	
10

	 	
3.02

	
-

	
Conduct of Business 

	
10

 

 

 

2

INDEX

 

 

	
ARTICLE IV - CONDITIONS PRECEDENT TO PERFORMANCE BY ATI

	10
	 	
4.01

	
-

	
Conditions 

	
10

	 	
4.02

	
-

	
Accuracy of Representations 

	
10

	 	
4.03

	
-

	
Performance

	
10

	 	
4.04

	
-

	
Absence of Litigation 

	
11

	 	
4.05

	
-

	
Other 

	
11

	 	 	 	 	 
	
ARTICLE V - CONDITIONS PRECEDENT TO PERFORMANCE BY GEI

	11
	 	
5.01

	
-

	
Conditions 

	
11

	 	
5.02

	
-

	
Accuracy of Representations 

	
11

	 	
5.03

	
-

	
Performance 

	
11

	 	
5.04

	
-

	
Absence of Litigation 

	
11

	 	
5.05

	
-

	
Other 

	
11

	 	 	 	 	 
	
ARTICLE VI - CLOSING

	12
	 	
6.01

	
-

	
Closing 

	
12

	 	
6.02

	
-

	
Exchange of Securities 

	
12

	 	
6.03

	
-

	
Officers and Directors 

	
12

	 	
6.04

	
-

	
Post-Closing Matters

	12
	 	 	 	 	12
	
ARTICLE VII - REMEDIES

	12
	 	
7.01

	
-

	
Arbitration 

	
12

	 	
7.02

	
-

	
Costs 

	
12

	 	
7.03

	
-

	
Termination 

	
12

	 	 	 	 	 
	
ARTICLE VIII - MISCELLANEOUS

	13
	 	
8.01

	
-

	
Captions and Headings 

	
13

	 	
8.02

	
-

	
No Oral Change 

	
13

	 	
8.03

	
-

	
Non-Waiver 

	
13

	 	
8.04

	
-

	
Time of Essence 

	
13

	 	
8.05

	
-

	
Entire Agreement 

	
13

	 	
8.06

	
-

	
Governing Law 

	
13

	 	
8.07

	
-

	
Counterparts 

	
13

	 	
8.08

	
-

	
Notices 

	
13

	 	
8.09

	
-

	
Binding Effect 

	
14

	 	
8.10

	
-

	
Effect of Closing 

	
14

	 	
8.11

	
-

	
Mutual Cooperation 

	
14

	 	
8.12

	
-

	
Expenses

	
14

 

 

 

3

INDEX

 

LIST OF SCHEDULES AND EXHIBITS

 

	 	
Exhibit A

	
-

	
Plan of Share Exchange 

	20
	 	
Exhibit B

	
-

	
Options, Warrants and Convertible Securities (ATI) 

	
20

	 	
Exhibit C

	
-

	
Officers and Directors Bank Accounts, Safe Deposit Boxes, Powers of Attorney (ATI)

	 21 
	 	
Exhibit D

	
-

	
Financial Statements – Changes in Financial Condition (ATI) 

	22
	 	
Exhibit E

	
-

	
Patents, Trademarks, Trade Names, and Copyrights (ATI)

	
23

	 	
Exhibit F

	
-

	
Material Contracts and Leases (ATI)

	
24

	 	
Exhibit G

	
-

	
Insurance Policies and Litigation (ATI)

	25
	 	
Exhibit H

	
-

	
Options, Warrants and Convertible Securities (GEI) 

	27
	 	
Exhibit I

	
-

	
Officers and Directors, Bank Accounts, Safe Deposit Boxes, Powers of Attorney (GEI)

	28
	 	
Exhibit J

	
-

	
Financial Statements – Changes in Financial Condition (GEI)

	29
	 	
Exhibit K

	
-

	
Patents, Trademarks, Trade Names and Copyrights (GEI) 

	30
	 	
Exhibit L

	
-

	
Material Contracts (GEI) 

	31
	 	
Exhibit M

	
-

	
Insurance Policies and Litigation (GEI) 

	32

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4

INDEX

 

AGREEMENT TO EXCHANGE SECURITIES

THIS AGREEMENT, made this 27th day of October, 2016, by and between Advantego Technologies, Inc. ("ATI") and Golden Eagle International, Inc. ("GEI"), is made for the purpose of setting forth the terms and conditions upon which GEI will acquire all the outstanding shares of ATI in exchange for shares of GEI's common stock.

In consideration of the mutual promises, covenants, and representations contained herein, the parties hereto agree as follows:

ARTICLE I

EXCHANGE OF SECURITIES

1.01 Subject to the terms and conditions of this Agreement, GEI agrees to issue 127,915,000 shares of GEI's common stock in exchange for all of the outstanding shares of ATI.  The shares of GEI will be issued to the ATI shareholders in accordance with the Plan of Share Exchange attached to this Agreement as Exhibit A.

It is intended that the Plan of Share Exchange shall constitute a reorganization within the meaning of Section 368 of the Internal Revenue Code of 1986, as amended (the "Code"), and that this Agreement shall constitute a "plan of reorganization" for the purposes of Section 368 of the Code.

ARTICLE II

REPRESENTATIONS AND WARRANTIES

2.01 Organization.  ATI is a corporation duly organized, validly existing, and in good standing under the laws of California, has all necessary corporate power to own its properties and to carry on its business as now owned and operated by it, and is duly qualified to do business and is in good standing in each of the states where its business requires qualification.

2.02 Capital.  The authorized capital stock of ATI consists of Ten thousand (10,000) shares of common stock and no shares of preferred stock, of which one thousand (1,000) shares of common stock are outstanding as of the date hereof.  At closing, ATI will not have any outstanding shares of preferred stock.  Other than as shown on Exhibit B, there are no subscriptions, options, rights, warrants, convertible securities, or other agreements or commitments outstanding obligating ATI to issue or to transfer from treasury any additional shares of its capital stock.  All outstanding shares of ATI are validly issued, fully paid and not assessable and not subject to any preemptive rights.

2.03 Directors' and Officers' Compensation; Banks.  Exhibit C to this Agreement contains: (i) the names and titles of all directors and officers of ATI and all persons whose compensation from ATI as of the date of this Agreement will equal or is expected to equal or exceed, at an annual rate, the sum of $1,000; (ii) the name and address of each bank with which ATI has an account or safety deposit box, and the names of all persons who are authorized to draw thereon or have access thereto; and (iii) the names of all persons who have a power of attorney from ATI and a summary of the terms thereof.

 

5

INDEX

2.04 Financial Statements.  Exhibit D to this Agreement contains the balance sheet of ATI as of September 30th, 2016 (the "ATI Financial Statements").  The ATI Financial Statements are complete and correct in all material respects and fairly present in all material respects the financial condition and results of operation of ATI at such date and for such period and show all material liabilities, absolute or contingent, of ATI.

2.05 Absence of Changes.  Since September 30, 2016, there has not been any change in the financial condition or results of operations of ATI, except changes reflected on Exhibit D or changes in the ordinary course of business, which changes have not in the aggregate been materially adverse.

2.06 Absence of Undisclosed Liabilities.  ATI did not as of September 30, 2016 have any debt, liability, or obligation of any nature, whether accrued, absolute, contingent, or otherwise, and whether due or to become due, that is not reflected on Exhibit D.

2.07 Tax Returns.  Within the times and in the manner prescribed by law, ATI has filed all federal, state, and local tax returns required by law and has paid all taxes, assessments, and penalties due and payable.  The provision for taxes, if any, reflected in ATI's balance sheet as of September 30, 2016, 2016 is adequate for any and all federal, state, county, and local taxes for the period ending on the date of that balance sheet and for all prior periods, whether or not disputed.  There are no present disputes as to taxes of any nature payable by ATI.

2.08 Investigation of Financial Condition.  Without in any manner reducing or otherwise mitigating the representations contained herein, GEI shall have the opportunity between the date of this Agreement and the Closing to meet with ATI's accountants and attorneys to discuss the financial condition of ATI.  ATI shall make available to GEI the books and records of ATI.  Such books and records have been maintained in the ordinary course of business, and are true and correct copies of such books and records.  The minutes of ATI are a complete and accurate record of all meetings of the shareholders and directors of ATI and accurately reflect all actions taken at such meetings.  The signatures of the directors and/or officers on such minutes are the valid signatures of ATI's directors and/or officers who were duly elected or appointed on the dates that the minutes were signed by such persons.  The stock book of ATI contains an accurate record of all transactions with respect to the capital stock of ATI.

2.09 Patents, Trademarks, Trade Names, and Copyrights.  Exhibit E attached hereto and made a part hereof lists all trademarks, trademark registrations or applications, trade names, service marks, patents, copyrights, copyright registrations or applications which are owned by ATI.  No person other than ATI owns any trademark, trademark registration or application, service mark, trade name, copyright, or copyright registration or application the use of which is necessary or contemplated in connection with the operation of ATI's business.

 

6

INDEX

2.10 Contracts and Leases.  Exhibit F attached hereto and made a part hereof contains a summary of the provisions of all material contracts, leases, and other agreements of ATI presently in existence or which have been agreed to by ATI (whether written or oral).  Except as disclosed on Exhibit F, ATI is not in default under of these agreements or leases.

2.11 Insurance Policies.  Exhibit G to this Agreement is a description of all insurance policies held by ATI concerning its business and properties.  All these policies are in the respective principal amounts set forth in Exhibit G and are in full force and effect.

2.12 Compliance with Laws.  ATI has complied with, and is not in violation of, applicable federal, state, or local statutes, laws, and regulations affecting its properties or the operation of its business, including, but not limited to, federal and state securities laws.

2.13 Litigation.  Other than as disclosed on Exhibit G, ATI is not a party to any suit, action, arbitration, legal, administrative, or other proceeding, or governmental investigation pending or, to the best knowledge of ATI, threatened against or affecting ATI or its business, assets, or financial condition.  ATI is not in default with respect to any order, writ, injunction, or decree of any federal, state, local, or foreign court, department, agency, or instrumentality.  ATI is not engaged in any legal action to recover moneys due to ATI or damages sustained by ATI.

2.14 Ability to Carry Out Obligations.  ATI has the right, power, and authority to enter into, and perform its obligations under, this Agreement.  The execution and delivery of this Agreement by ATI and the performance by ATI of its obligations hereunder will not cause, constitute, or conflict with or result in (a) any breach or violation of any of the provisions of or constitute a default under any license, indenture, mortgage, charter, instrument, articles of incorporation, by-law, or other agreement or instrument to which ATI is a party, or by which it may be bound, nor will any consents or authorizations of any party other than those hereto be required, (b) an event that would permit any party to any agreement or instrument to terminate it or to accelerate the maturity of any indebtedness or other obligation of ATI, or (c) an event that would result in the creation or imposition or any lien, charge, or encumbrance on any asset of ATI or would create any obligations for which ATI would be liable, except as contemplated by this Agreement.

2.15 Full Disclosure.  None of the representations and warranties made by ATI, or in any certificate or memorandum furnished or to be furnished by ATI, or on its behalf, contains or will contain any untrue statement of material fact, or omit any material fact the omission of which would be misleading.

2.16 Assets.   ATI has good and marketable title to all of its property, free and clear of all mortgages, liens pledges, charges, encumbrances or interest of any third party whatsoever.

2A. Organization.  GEI is a corporation duly organized, validly existing, and in good standing under the laws of Colorado, has all necessary corporate powers to own its properties and to carry on its business as now owned and operated by it, and is duly qualified to do business and is in good standing in each of the states where its business requires qualification, except in those states where the failure to be so qualified would not have a material adverse effect on GEI.

 

7

INDEX

2B. Capital.  The authorized capital stock of GEI consists of 2,000,000,000 shares of common stock and 10,000,000 shares of preferred stock.  Immediately prior to closing, 27,378,688 shares of common stock and 240,000 shares of Series B preferred stock will be outstanding.  All such shares are validly issued, fully paid, and non-assessable.  At Closing, there will be no outstanding subscriptions, options, rights, warrants, convertible securities, or other agreements or commitments obligating GEI to issue or to transfer from treasury any additional shares of its capital stock of any class except as reflected on Exhibit H.

2C. Directors' and Officers' Compensation; Banks.  Exhibit I to this Agreement contains: (i) the names and titles of all directors and officers of GEI and all persons whose compensation from GEI as of the date of this Agreement will equal or is expected to equal or exceed, at an annual rate, the sum of $1,000; (ii) the name and address of each bank with which GEI has an account or safety deposit box, and the names of all persons who are authorized to draw thereon or have access thereto; and (iii) the names of all persons who have a power of attorney from GEI and a summary of the terms thereof.

2D. Financial Statements.  Exhibit J to this Agreement sets forth the balance sheet of GEI as of October 18, 2016, (the "GEI Financial Statements").  The GEI Financial Statements comply as to form in all material respects with applicable requirements of the U.S. Securities and Exchange Commission with respect thereto, are accurate and in accordance with the books and records of GEI, have been prepared in accordance with generally accepted accounting principles applied on a consistent basis during the period involved, except as may be indicated in the notes thereto or as permitted by rules of the Securities and Exchange Commission.

2E. Absence of Changes.  Since October 18, 2016, there has not been any material change in the financial condition or operations of GEI, except (i) changes in the ordinary course of business, which changes have not in the aggregate been materially adverse, and (ii) changes disclosed on Exhibit J.

2F. Absence of Undisclosed Liabilities.  GEI did not as of October 18, 2016 have any debt, liability, or obligation of any nature, whether accrued, absolute, contingent, or otherwise, and whether due or to become due, that is not reflected on Exhibit J.

2G. Tax Returns.  Within the times and in the manner prescribed by law, GEI has filed all federal, state, and local tax returns required by law and has paid all taxes, assessments, and penalties due and payable, except where the failure to file and/or pay would not have a material adverse effect on GEI.  No federal income tax returns of GEI have been audited by the Internal Revenue Service.  The provision for taxes, if any, reflected in GEI's balance sheet as of October 18, 2016, is adequate for any and all federal, state, county, and local taxes for the period ending on the date of that balance sheet and for all prior periods, whether or not disputed.  There are no present disputes as to taxes of any nature payable by GEI.

 

8

INDEX

2H. Investigation of Financial Condition of GEI.  Without in any manner reducing or otherwise mitigating the representations contained herein, ATI shall have the opportunity to meet with GEI's accountants and attorneys to discuss the financial condition of GEI.  GEI shall make available to ATI the books and records of GEI.  The minutes of GEI are a complete and accurate record of all meetings of the shareholders and directors of GEI and accurately reflect all actions taken at such meetings.  The signatures of the directors and/or officers on such minutes are the valid signatures of GEI's directors and/or officers who were duly elected or appointed on the dates that the minutes were signed by such persons.

2I. Patents, Trademarks, Trade Names, and Copyrights.  Exhibit K attached hereto and made a part hereof lists all trademarks, trademark registrations or applications, trade names, service marks, patents, copyrights, copyright registrations or applications which are owned by GEI.  No person other than GEI owns any trademark, trademark registration or application, service mark, trade name, copyright, or copyright registration or application the use of which is necessary or contemplated in connection with the operation of GEI's business.

2J. Contracts and Leases.  Exhibit L, attached hereto and made a part hereof, contains a summary of the provisions of all material contracts, leases and other agreements of GEI presently in existence or which have been agreed to by GEI (whether written or oral).  Except as disclosed on Exhibit L, GEI is not in default under of these agreements or leases.

2K. Insurance Policies.  Exhibit M to this Agreement is a description of all insurance policies held by GEI concerning its business and properties.  All these policies are in the respective principal amounts set forth in Exhibit M and are in full force and effect.

2L. Compliance with Laws.  GEI has complied with, and is not in violation of, applicable federal, state, or local statutes, laws, and regulations affecting its properties or the operation of its business.  GEI does not have any employee benefit plan which is subject to the provisions of the Employee Retirement Income Security Act of 1974.  Neither GEI nor its officers/directors are currently or have previously been under investigation by any regulatory agency.  GEI has never had any consent decrees or enforcement actions brought against it.  Notwithstanding the above, ATI understands that GEI has not filed its 10-K reports for the years ending December 31, 2013, 2014 and 2015 with the Securities and Exchange Commission.

2M. Litigation.  Other than as disclosed on Exhibit M, GEI is not a party to any suit, action, arbitration, legal, administrative, or other proceeding, or governmental investigation pending or, to the best knowledge of GEI, threatened against or affecting GEI or its business, assets, or financial condition.  GEI is not in default with respect to any order, writ, injunction, or decree of any federal, state, local, or foreign court, department, agency, or instrumentality.  GEI is not engaged in any legal action to recover moneys due to it or damages sustained by it other than as disclosed on Exhibit M.

2N. Ability to Carry Out Obligations.  GEI has the right, power, and authority to enter into, and perform its obligations under, this Agreement.  The execution and delivery of this Agreement by GEI and the performance by GEI of its obligations hereunder will not cause, constitute, or conflict with or result in (a) any breach or violation of any of the provisions of or constitute a default under any license, indenture, mortgage, charter, instrument, articles of incorporation, by-law, or other agreement or instrument to which GEI is a party, or by which it may be bound, nor will any consents or authorizations of any party other than those hereto be required, (b) an event that would permit any party to any agreement or instrument to terminate it or to accelerate the maturity of any indebtedness or other obligation of GEI, or (c) an event that would result in the creation or imposition or any lien, charge, or encumbrance on any asset of GEI or would create any obligations for which GEI would be liable, except as contemplated by this Agreement.

 

9

INDEX

2O. Full Disclosure.  None of the representations and warranties made by GEI in any certificate or memorandum furnished or to be furnished by GEI, or on its behalf, contains or will contain any untrue statement of material fact, or omit any material fact the omission of which would be misleading.  GEI has disclosed to ATI all reasonably foreseeable contingencies which, if such contingencies transpire, would have a material adverse effect on GEI.

2P. Assets.  GEI has good and marketable title to all of its property, free and clear of all mortgages, liens pledges, charges, encumbrances or interest of any third party whatsoever.

ARTICLE III

OBLIGATIONS BEFORE CLOSING

3.01 Investigative Rights.  From the date of this Agreement until the date of closing, each party shall provide to the other party, and such other party's counsel, accountants, auditors, and other authorized representatives, full access during normal business hours to all of each party's properties, books, contracts, commitments, records and correspondence and communications with regulatory agencies for the purpose of examining the same.  Each party shall furnish the other party with all information concerning each party's affairs as the other party may reasonably request.

3.02 Conduct of Business.  Prior to the closing, and except as contemplated by this Agreement, each party shall conduct its business in the normal course, and shall not sell, pledge, or assign any assets, without the prior written approval of the other party, except in the regular course of business.  Except as contemplated by this Agreement, neither party to this Agreement shall issue or sell any shares, stock, options or other securities, amend its Articles of Association, Articles of Incorporation or By-laws, declare dividends, redeem or sell stock or other securities, incur additional or newly-funded material liabilities, acquire or dispose of fixed assets, change senior management, change employment terms, enter into any material or long-term contract, guarantee obligations of any third party, settle or discharge any balance sheet receivable for less than its stated amount, pay more on any liability than its stated amount, or enter into any other transaction other than in the regular course of business, or  enter into any agreement or take any action that is likely to cause any of the representations and warranties of such party under this Agreement not to be true and correct as of the Closing, or that is likely to affect the Closing.  Notwithstanding the above, ATI's is directed to GEI's preliminary proxy statement filed with the Securities and Exchange Commission on August 25, 2016 for information concerning matters to be considered at a special meeting, yet to be scheduled, of GEI's shareholders.

 

10

INDEX

ARTICLE IV

CONDITIONS PRECEDENT TO PERFORMANCE BY GEI

4.01 Conditions.  GEI's obligations hereunder shall be subject to the satisfaction, at or before the Closing, of all the conditions set forth in this Article IV.  GEI may waive any or all of these conditions in whole or in part without prior notice; provided, however, that no such waiver of a condition shall constitute a waiver by GEI of any other condition of or any of GEI's other rights or remedies, at law or in equity, if ATI shall be in default of any of its representations, warranties, or covenants under this agreement.

4.02 Accuracy of Representations.  Except as otherwise permitted by this Agreement, all representations and warranties by ATI in this Agreement or in any written statement that shall be delivered to GEI by ATI under this Agreement shall be true on and as of the Closing Date as though made at those times.

4.03 Performance.  ATI shall have performed, satisfied, and complied with all covenants, agreements, and conditions required by this Agreement to be performed or complied with by it, on or before the closing.  ATI shall have obtained all necessary consents and approvals necessary to consummate the transactions contemplated hereby.

4.04 Absence of Litigation.  No action, suit, or proceeding before any court or any governmental body or authority, pertaining to the transaction contemplated by this agreement or to its consummation, shall have been instituted or threatened on or before the Closing.

4.05 Other.  In addition to the other provisions of this Article IV, GEI's obligations hereunder shall be subject to the satisfaction of the following:

		●	
the directors and shareholders of ATI will have approved the Plan of Share Exchange;

		●	
the liabilities of ATI will not exceed those shown on Exhibit D;

		●	
ATI will not have more than one thousand (1,000) outstanding shares of common stock; and

ARTICLE V

CONDITIONS PRECEDENT TO PERFORMANCE BY ATI

5.01 Conditions.  ATI's obligations hereunder shall be subject to the satisfaction, at or before the Closing, of the conditions set forth in this Article V.  ATI may waive any or all of these conditions in whole or in part without prior notice; provided, however, that no such waiver of a condition shall constitute a waiver by ATI of any other condition of or any of ATI's other rights or remedies, at law or in equity, if GEI shall be in default of any of its representations, warranties, or covenants under this agreement.

 

11

INDEX

5.02 Accuracy of Representations.  Except as otherwise permitted by this Agreement, all representations and warranties by GEI in this Agreement or in any written statement that shall be delivered to ATI by GEI under this Agreement shall be true on and as of the Closing Date as though made at those times.

5.03 Performance.  GEI shall have performed, satisfied, and complied with all covenants, agreements, and conditions required by this Agreement to be performed or complied with by it, on or before the closing.  GEI shall have obtained all necessary consents and approvals necessary to consummate the transactions contemplated hereby.

5.04 Absence of Litigation.  No action, suit, or proceeding before any court or any governmental body or authority, pertaining to the transaction contemplated by this agreement or to its consummation, shall have been instituted or threatened on or before the closing.

5.05 Other.  In addition to the other provisions of this Article V, ATI's obligations hereunder shall be subject to the satisfaction of the following:

		●	
the directors of GEI will have approved the Plan of Share Exchange;

		●	
The liabilities of GEI will not exceed $242,612.23 (post-closing); and

		●	
GEI will not have more than 27,378,688 outstanding shares of common stock.

ARTICLE VI

CLOSING

 

6.01 Closing.  The closing of this transaction shall be held at the offices of Hart and Hart, or such other location as the parties may agree. Unless the closing of this transaction takes place before November 15, 2016, then either party may terminate this Agreement without liability to the other party, excluding claims for breaches of obligations by any party hereto prior to such termination.

6.02 Exchange of Securities.  On the closing date, each outstanding share of the common stock of ATI will be exchanged for one fully paid and non-assessable share of GEI.

6.03 Officer and Directors.  At the closing of this Agreement, GEI will cause Fred Popke, Robert W. Ferguson, John J. Carvelli, and Barry Adnams to be appointed as directors of GEI.  Simultaneous with such appointment, all officers of GEI will resign and all directors of GEI, with the exception of Philip Grey, will resign.

6.04 Post-Closing Matters.

Promptly after the closing, GEI will transfer the Gold Bar Mill to a subsidiary of GEI.  The shares of the subsidiary will be transferred to a trustee who will hold the shares, pending the distribution of the shares, on a prorata basis, to GEI's shareholders of record immediately prior to the closing of this transaction, excepting shareholders who own less than 11 shares of the Company's common stock.

 

12

INDEX

Promptly after the closing, Gulf Coast Capital, LLC will sell 160,000 shares of GEI's Series B preferred stock to Robert Ferguson and Fred Popke for $10.00.

 

After the closing, promissory notes in the principal amount of $115,000 will be converted into 4,600,000 shares of GEI's common stock.

ARTICLE VII

REMEDIES

7.01 Arbitration. Any dispute in any way involving this Agreement will be settled through binding arbitration in accordance with the Commercial Rules of the American Arbitration Association in Denver, Colorado.

7.02 Costs. If any legal action or any arbitration or other proceeding is brought for the enforcement of this Agreement, or because of an alleged dispute, breach, default, or misrepresentation in connection with any of the provisions of this Agreement, the successful or prevailing party or parties shall be entitled to recover reasonable attorney's fees and other costs incurred in that action or proceeding, in addition to any other relief to which it or they may be entitled.

7.03 Termination.  In addition to the other remedies, GEI or ATI may on or prior to the Closing Date terminate this Agreement, without liability to the other party:

(i) If any bona fide action or proceeding shall be pending against GEI or ATI on the Closing Date that could result in an unfavorable judgment, decree, or order that would prevent or make unlawful the carrying out of this Agreement or if any agency of the federal or of any state or national government shall have objected at or before the closing date to this acquisition or to any other action required by or in connection with this Agreement;

(ii) If the legality and sufficiency of all steps taken and to be taken by each party in carrying out this Agreement shall not have been approved by the respective party's counsel, which approval shall not be unreasonably withheld.

(iii) If a party breaches any representation, warranty, covenant or obligation of such party set forth herein and such breach is not corrected within ten days of receiving written notice from the other party of such breach.

ARTICLE VIII

MISCELLANEOUS

8.01 Captions and Headings.  The Article and paragraph headings throughout this Agreement are for convenience and reference only, and shall in no way be deemed to define, limit, or add to the meaning of any provision of this Agreement.

 

13

INDEX

8.02 No Oral Change.  This Agreement and any provision hereof, may not be waived, changed, modified, or discharged orally, but only by an agreement in writing signed by all parties hereto.

8.03 Non-Waiver.  Except as otherwise expressly provided herein, no waiver of any covenant, condition, or provision of this Agreement shall be deemed to have been made unless expressly in writing and signed by the party against whom such waiver is charged; and (i) the failure of any party to insist in any one or more cases upon the performance of any of the provisions, covenants, or conditions of this Agreement or to exercise any option herein contained shall not be construed as a waiver or relinquishment for the future of any such provisions, covenants, or conditions, (ii) the acceptance of performance of anything required by this Agreement to be performed with knowledge of the breach or failure of a covenant, condition, or provision hereof shall not be deemed a waiver of such breach or failure, and (iii) no waiver by any party of one breach by another party shall be construed as a waiver with respect to any other or subsequent breach.

8.04 Time of Essence.  Time is of the essence of this Agreement and of each and every provision hereof.

8.05 Entire Agreement.  This Agreement contains the entire Agreement and understanding between the parties hereto, and supersedes all prior agreements, understandings and the letters of intent between the parties.

8.06 Governing Law.  This Agreement and its application shall be governed by the laws of Colorado.

8.07 Counterparts.  This Agreement may be executed simultaneously in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

8.08 Notices.  All notices, requests, demands, and other communications under this Agreement shall be in writing and shall be deemed to have been duly given on the date of service if served personally on the party to whom notice is to be given, or on the third day after mailing if mailed to the party to whom notice is to be given, by first class mail, registered or certified, postage prepaid, and properly addressed as follows:

Advantego Technologies, Inc.

1 Park Plaza, Suite 600

Irvine, CA  92614

Golden Eagle International, Inc.

3934 Platte Ave.

Sedalia, CO 80135

 

14

INDEX

With copy to:

Hart & Hart, LLC

1624 Washington Street

Denver, CO 80203

8.09 Binding Effect.  This Agreement will be binding upon the parties herein even though this Agreement may not be signed by all persons whose names appear on the signature page of this Agreement. This Agreement shall inure to and be binding upon and be enforceable against the respective successors of each of the parties to this Agreement.   No party may assign or transfer any of its rights or obligations hereunder, without the prior written consent of the other parties hereto. Nothing in this Agreement, express or implied, shall give to any person other than the parties hereto any benefit or any legal or equitable right, remedy or claim under this Agreement.

8.10 Effect of Closing.  All representations, warranties, covenants, and agreements of the parties contained in this Agreement, or in any instrument, certificate, opinion, or other writing provided for in it, shall survive the closing of this Agreement and shall remain in effect for a period of twelve months thereafter.  In the event there is any material misrepresentation or warranty of any party to this Agreement, then GEI (if such misrepresentation is made by ATI) or ATI (if such misrepresentation is made by GEI) may rescind this Agreement during the 90-day period following the closing of this Agreement.

8.11 Mutual Cooperation.  The parties hereto shall cooperate with each other to achieve the purpose of this Agreement, and shall execute such other and further documents and take such other and further actions as may be necessary or convenient to affect the transaction described herein.  Neither party will intentionally take any action, or omit to take any action, which will cause a breach of such party's obligations pursuant to this Agreement.

8.12 Expenses.  Each of the parties hereto agrees to pay all of its own expenses (including without limitation, attorneys' and accountants' fees) incurred in connection with this Agreement, the transactions contemplated herein and negotiations leading to the same and the preparations made for carrying the same into effect.  Each of the parties expressly represents and warrants that no finder or broker has been involved in this transaction and each party agrees to indemnify and hold the other party harmless from any commission, fee or claim of any person, firm or corporation employed or retained by such party (or claiming to be employed or retained by such party) to bring about or represent such party in the transactions contemplated by this Agreement.

 

 

 

 

 

 

 

 

 

15

INDEX

 

AGREED TO AND ACCEPTED as of the date first above written.

 

 

	 	ADVANTEGO TECHNOLOGIES, INC.	 
	 	 	 	 
	 	 	 	 
	
 

	
By: 

	/s/ Robert W. Ferguson	 
	 	 	Robert W. Ferguson, Chief Executive Officer	 
	 	 	 	 
	 	 	 	 
	 	GOLDEN EAGLE INTERNATIONAL, INC.	 
	 	 	 	 
	 	 	 	 
	 	By:	/s/ Mark Bogani	 
	 	 	Mark Bogani, Chief Executive Officer	 

 

 

 

 

 

 

 

 

  

 

16

INDEX

  

EXHIBIT A

PLAN OF SHARE EXCHANGE

The following is the Plan of Share Exchange between Golden Eagle International, Inc. and Advantego Technologies, Inc.

	
Acquiring entity:

	
Golden Eagle International, Inc.

	 	 
	
Entity being acquired:

	
Advantego Technologies, Inc.

	 	 
	
Share exchange:

	
Golden Eagle International, Inc. will issue shares of its restricted common stock for the outstanding shares of Advantego Technologies, Inc.  The shares will be issued to the persons shown below.

	 	 	
Advantego

	 	 	
Shares of GEI

	 
	 	 	
Shares Owned

	 	 	
to be Received

	 
	 	 	 	 	 	 	 
	
Robert W. Ferguson

	 	 	
406

	 	 	 	
51,933,490

	 
	
Robert J. Ferguson III

	 	 	
35

	 	 	 	
4,477,025

	 
	
Matthew and Christina Petteruto

	 	 	
15

	 	 	 	
1,918,725

	 
	
Aaron and Jacquelyn Stubblefield

	 	 	
24

	 	 	 	
3,069,960

	 
	
Stephanie N. Ferguson

	 	 	
10

	 	 	 	
1,279,150

	 
	
Robert J. and Irene L. Ferguson

	 	 	
10

	 	 	 	
1,279,150

	 
	
Fred Popke

	 	 	
410

	 	 	 	
52,445,150

	 
	
Titus A. Thobias

	 	 	
30

	 	 	 	
3,837,450

	 
	
Janisha Titus

	 	 	
20

	 	 	 	
2,558,300

	 
	
Christopher Popke

	 	 	
10

	 	 	 	
1,279,150

	 
	
Joshua Popke

	 	 	
10

	 	 	 	
1,279,150

	 
	
David Popke

	 	 	
10

	 	 	 	
1,279,150

	 
	
Kurt Popke

	 	 	
10

	 	 	 	
1,279,150

	 
	 	 	 	 	 	 	 	 	 
	 	 	 	
1,000

	 	 	 	
127,915,000

	 

 

 

 

17

INDEX

  

EXHIBIT B

OPTIONS, WARRANTS AND CONVERTIBLE SECURITIES (ATI)

 

 

None at this time

 

 

 

 

 

 

 

 

 

 

 

 

  

18

INDEX

 

EXHIBIT C

Officers and Directors (ATI)

 

	
Name

	 	
Position

	 	 	 
	
Robert W. Ferguson

	 	
Chief Executive Officer, Director

	 	 	 
	Fred Popke	 	
Vice President, Secretary, Treasurer & Director

	 	 	 
	
Cal L. Engstrom, Esq.

	 	
Director

 

 

 

 

 

 

 

 

 

 

 

 

 

 

19

INDEX

EXHIBIT D

Financial Statements- Changes in

Financial Condition (ATI)

Financial Statement

As of September 30, 2016

(Unaudited)

 

	
Assets:

	 	 	 
	 	 	 	 
	
Cash/Cash Equivalent

	 	
$

	
30,917.75

	 
	
Short Term Investments

	 	$	
- 0 - 

	 
	
Net Receivables

	 	
$

	
- 0 -

	 
	
Property Plant & Equipment

	 	
$

	
- 0 -

	 
	
Other Assets

	 	
$

	
- 0 -

	 
	 	 	 	 	 
	
Total Assets

	 	
$

	
30,917.75

	 
	 	 	 	 	 
	
Current Liabilities:

	 	 	 	 
	 	 	 	 	 
	
Accounts Payable

	 	
$

	
- 0 -

	 
	
Loan – Golden Eagle International

	 	
$

	
50,000.00

	 
	
Other Current Liabilities

	 	
$

	
- 0 -

	 
	
Total Current Liabilities

	 	
$

	
50,000.00

	 
	
Long Term Debt

	 	
$

	
- 0 -

	 
	
Other Liabilities

	 	
$

	
- 0 -

	 
	 	 	 	 	 
	
Total Liabilities

	 	
$

	
50,000.000

	 
	 	 	 	 	 
	
Stock Holder's Equity

	 	 	 	 
	 	 	 	 	 
	
Common Stock

	 	
$

	
1,000.00

	 
	
Total Stockholder Equity

	 	
$ 

	
(19,082.25

	
)

	 	 	 	 	 
	
Net Tangible Assets

	 	
$ 

	
(19,082.25

	
)

Note(s): Company was incorporated in California on July 29, 2016 and as of this date, has acquired numerous proprietary licensing agreements for specific software from its majority shareholders at substantially less than fair market value and are carried at no value on the books of the company. In addition, the company has not generated any revenue from inception to the date above.

 

 

20

INDEX

 

 

EXHIBIT E

Patents, Trademarks, Trade Names and

Copyrights (ATI)

Patents:

Trademarks/Tradename:    ADVANTEGO (Application Filed)

Trade Names   -

Copyrights:

 

 

 

 

 

 

 

 

 

 

  

21

INDEX

 

EXHIBIT F

Material Contracts, Leases, Licenses & Assignments (ATI)

		1.	
Office Lease at Premier Business Centers

		2.	
City of Irvine Business License

		3.	
Text Power Agreement

		4.	
America West Natural Hazard Insurance Agreement

		5.	
Loanry Agreement

		6.	
Prototype Software Assignment

		7.	
Assignments of Domain Names:

Advantego.com

AutoRepair.Solutions

BailBondPremiumFinancing.com

BailBonds.Directory

PromoText.Solutions

PromoTexting.com

PromoTextSolutions.com

HomeImprovementPromo.com

HomeImprovementPromotionscom

ImprovementDeals.com

ImprovementOffer.com

ImprovementOffers.com

ImprovementPromo.Com

		8.	
Promo Text Software Agreement

		9.	
Licensing Agreement – REST

  

22

INDEX

 

EXHIBIT G

Insurance Policies (ATI)

 

	
Policy

	
 

	
Insurer

	 	

Coverage

Limit

	 	
Expiration

Date

 

None

 

 

 

Litigation (ATI)

 

	
Case Name

	 	
Case Number

	 	
Disposition

	 	
Description

 

None

 

 

 

 

 

 

 

 

 

 

 

 

 

23

INDEX

  

EXHIBIT H

Options, Warrants and Convertible Securities (GEI)

		1.	
GEI has 2,000,000 outstanding

 

	
●

	
Series A warrants

	
●

	
Series B warrants

	
●

	
Series C warrants

Each Series A warrant allows the holder to purchase one share of the Company's common stock at a price of $0.05 per share at any time on or before June 30, 2017.

Each Series B warrant allows the holder to purchase one share of the Company's common stock at a price of $.10 per share at any time on or before June 30, 2018.

Each Series C warrant allows the holder to purchase one share of the Company's common stock at a price of $0.20 per share any time on or before June 30, 2019.

The Series B warrants may be exercised by means of a "cashless" exercise.

		2.	
GEI has a note payable to Clifford Thygesen in the principal amount of $50,000.  The note is convertible, at the option of Mr. Thygesen, into shares of GEI's common stock at a conversion rate of $0.025 per share.

24

INDEX

EXHIBIT I

Officers and Directors (GEI)

 

	
Name

	 	
Position

	 	 	 
	
Mark Bogani

	 	
President, Chief Executive Officer and a Director

	 	 	 
	
Philip F. Grey

	 	
Chief Financial Officer and a Director

Bank Accounts, Safe Deposit

Boxes, Powers of Attorney (GEI)

First Bank

5150 DTC Blvd.

Greenwood Village, CO  80111

Acct. No. 3661242282

No safe deposit boxes or powers of attorneys

 

 

 

 

 

 

 

 

 

 

 

 

25

INDEX

 

 

EXHIBIT J

Financial Statements- Changes in Financial

 Condition (GEI)

	
Golden Eagle International, Inc.

	 	 	 
	
Balance Sheet

	 	 	 
	 	 	 	 
	
 

	 	 	 
	
 

	 	
October 18,

2016

	 
	
 

	 	 	 
	
ASSETS

	 	 	 
	
 

	 	 	 
	
CURRENT ASSETS

	 	 	 
	
Cash

	 	
$

	
74,254.00

	 
	
Loan – Advantego

	 	 	
50,000.00

	 
	 	 	 	 	 
	
FIXED ASSETS

	 	 	 	 
	 	 	 	 	 
	
Gold Bar Mill and Plant

	 	 	
3,980,000.00

	 
	
 

	 	 	 	 
	
TOTAL ASSETS

	 	
$

	
4,104,254.00

	 
	 	 	 	 	 
	
LIABILITIES AND STOCKHOLDERS' EQUITY

	 	 	 	 
	 	 	 	 	 
	
LIABILITIES

	 	 	 	 
	 	 	 	 	 
	
Current Liabilities

	 	 	 	 
	
Accounts Payable

	 	 	
23,563.28

	 
	 	 	 	 	 
	
Notes Payable - Related Parties

	 	 	
792,278.28

	 
	 	 	 	 	 
	
Accrued Interest

	 	 	
136,547.80

	 
	 	 	 	 	 
	
Total Current Liabilities

	 	 	
952,389.36

	 
	 	 	 	 	 
	
Long Term Liabilities

	 	 	 	 
	
Debenture – Clifford Thygesen

	 	 	
50,000.00

	 
	
Acc Int - Debentures

	 	 	
65.75

	 
	 	 	 	 	 
	
TOTAL LIABILITIES

	 	 	
1,002,455.11

	 
	
 

	 	 	 	 
	
EQUITY 

	 	 	 	 
	
Common Stock

	 	 	
2,736.01

	 
	
Preferred Stock

	 	 	
1,800.00

	 
	 	 	 	 	 
	
Additional Paid in Capital

	 	 	
64,702,484.64

	 
	 	 	 	 	 
	
Retained Earnings

	 	 	
(61,548,933.59

	
)

	
Net (Loss)

	 	 	
(56,288.17

	
)

	 	 	 	 	 
	
TOTAL EQUITY

	 	 	
3,101,798.89

	 
	 	 	 	 	 
	
TOTAL LIABILITIES AND EQUITY

	 	
$

	
4,104,254.00

	 

 

  

26

INDEX

EXHIBIT K

Patents, Trademarks, Trade Names and Copyrights (GEI)

None

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

27

INDEX

EXHIBIT L

Material Contracts (GEI)

None

 

 

 

 

 

 

 

 

 

 

 

 

 

 

28

INDEX

EXHIBIT M

Insurance Policies (GEI)

None

Litigation (GEI)

None

 

29

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00285-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00285-of-00352.parquet"}]]